These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
99 related items for PubMed ID: 4894225
1. [Some bacteriological and clinical aspects of the treatment or chronic pyelonephritis with Negram]. Liwski R, Gietko G. Pol Arch Med Wewn; 1969 May; 42(5):759-66. PubMed ID: 4894225 [No Abstract] [Full Text] [Related]
2. [Antibacterial effect of nalidixic acid in experimental acute Escherichia coli pyelonephritis]. Prát V, Konícková L, Ritzerfeld W, Losse H. Arztl Forsch; 1968 Feb 10; 22(2):69-72. PubMed ID: 4876157 [No Abstract] [Full Text] [Related]
3. [Use of nevigramon in acute and chronic pyelonephritis before and after kidney transplantation]. Iarmolinskiĭ IS, Vasina TA, Ploshkina NS, Goriaĭnov VA. Antibiotiki; 1971 Feb 10; 16(2):177-9. PubMed ID: 4997523 [No Abstract] [Full Text] [Related]
4. [Experience with nalidixic acid in pyelonephritis in children]. Zapp E. Arch Kinderheilkd; 1968 Apr 10; 177(1):53-60. PubMed ID: 4880029 [No Abstract] [Full Text] [Related]
7. [Evaluation of the effect of nalidixic acid on experimental E. coli ascendent or hematogenous pyelonephritis]. Prát V, Konícková L, Hatala M, Urbanová D. Cas Lek Cesk; 1968 Dec 06; 107(50):1515-20. PubMed ID: 4885857 [No Abstract] [Full Text] [Related]
10. Evaluation of the antibacterial effect of nalidixic acid in two experimental models of Escherichia coli pyelonephritis. Prát V, Konícková L, Hatala M, Urbanová D. Br J Exp Pathol; 1968 Feb 06; 49(1):60-7. PubMed ID: 4867859 [No Abstract] [Full Text] [Related]
12. [Inhibitory action of nitrofurantoin on the bacteriostatic power in vitro of nalidixic acid]. Piguet JD. Ann Inst Pasteur (Paris); 1969 Jan 06; 116(1):43-8. PubMed ID: 4890584 [No Abstract] [Full Text] [Related]
15. [Character of the effect of nalidixic acid (negram) on Escherichia coli strain 613]. Planel'es KhKh, Andreeva AM, Moroz AF. Antibiotiki; 1968 Jul 06; 13(7):617-20. PubMed ID: 4880236 [No Abstract] [Full Text] [Related]
16. Nalidixic acid in urinary infection. Neogy KN, De MS, Chatterjee ML. Bull Calcutta Sch Trop Med; 1968 Jan 06; 16(1):11-2. PubMed ID: 4890385 [No Abstract] [Full Text] [Related]
17. Risk factors for quinolone-resistance in women presenting with Escherichia coli acute pyelonephritis. Bedoin M, Cazorla C, Lucht F, Berthelot P, Boyer M, Carricajo A, Guérin T, Viallon A. Med Mal Infect; 2014 May 06; 44(5):206-16. PubMed ID: 24794820 [Abstract] [Full Text] [Related]
19. [Clinical evaluation of nalidixic acid (nevigramon) in the treatment of chronic pyelonephritis]. Chodorowski Z, Hebanowski M. Pol Tyg Lek; 1973 Aug 13; 28(33):1282-4. PubMed ID: 4742302 [No Abstract] [Full Text] [Related]
20. [Therapy of experimental ascending E. coli pyelonephritis with anlidixic acid]. Konícková L, Prát V, Hatala M, Urbanová D. Rozhl Chir; 1968 Nov 13; 47(10):745-50. PubMed ID: 4883721 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]